IPSC
Century Therapeutics, Inc.
+0.03 (+1.61%)1.89USD134K成交股數342M市值–本益比(近四季)3.1股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | 109M+12668% | 4.2M+2719% | 791K+699% | 771K-55% | 855K | 148K | 99K | 1.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 19.6M | 17.1M | 12K | 26.9M | 26.6M | 29.4M | 27.2M | 27.2M | 23.4M | 22.8M | 22.7M | 24.9M |
| 銷售管理費用 | 5.8M | 6.6M | 6.8M | 7.8M | 8.4M | 7.8M | 8.4M | 8.3M | 8.7M | 9.0M | 8.2M | 8.9M |
| 營業利益 | −36.5M-149% | −23.7M-36% | −36.1M+4% | −34.7M-0% | 74.2M-337% | −37.3M+5% | −34.8M-1% | −34.8M+8% | −31.3M | −35.6M | −35.1M | −32.1M |
| 營業利益率 | – | – | – | – | 67.9% | -893.7% | -4,398.1% | -4,507.8% | -3,661.9% | -24,071.6% | -35,431.3% | -1,865.2% |
| 稅後淨利 | −34.6M-145% | −21.6M-40% | −34.4M+10% | −32.5M+4% | 76.6M-373% | −36.1M+10% | −31.2M-6% | −31.2M-0% | −28.1M | −32.7M | −33.3M | −31.3M |
| 淨利率 | – | – | – | – | 70.1% | -864.6% | -3,947.7% | -4,047.6% | -3,282.1% | -22,108.1% | -33,627.3% | -1,817.7% |
| 稀釋 EPS | -0.17-119% | -0.11-73% | -0.40+8% | -0.380% | 0.89-298% | -0.41-25% | -0.37-34% | -0.38-28% | -0.45 | -0.55 | -0.56 | -0.53 |
| 稀釋股數 | 206M | 193M | 86.5M | 86.2M | 86.1M | 78.6M | 84.7M | 82.1M | 62.3M | 59.4M | 59.3M | 58.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 49.6M | 51.0M | 55.5M | 56.9M | 51.9M | 58.4M | 52.6M | 41.5M | 46.8M | 55.3M | 64.4M | 86.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 287M | 327M | 245M | 285M | 316M | 353M | 389M | 416M | 349M | 398M | 417M | 456M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | 10.4M |
| 總負債 | 54.7M | 61.8M | 68.4M | 74.8M | 75.2M | 192M | 193M | 194M | 171M | 178M | 170M | 179M |
| 股東權益 | 232M | 265M | 176M | 210M | 240M | 161M | 196M | 222M | 178M | 219M | 248M | 277M |
| 負債比 | 19.0% | 18.9% | 27.9% | 26.3% | 23.8% | 54.3% | 49.6% | 46.7% | 49.0% | 44.9% | 40.7% | 39.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | 76.4M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −25.3M | – | – | −34.6M+14% | – | – | – | −30.2M | – | – | −29.2M |
| 資本支出 | – | 584K | – | – | 475K | – | – | – | 539K | – | – | 5.0M |
| 自由現金流 | – | −25.8M | – | – | −35.1M+14% | – | – | – | −30.8M | – | – | −34.2M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | -32.2% | – | – | – | -3,600.8% | – | – | -1,989.0% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 109M
| Single Reportable | 109M | 100.0% | +1556.8% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 109M | +1556.8% | −9.6M | -8.8% | -0.14 | −105M |
| FY2024 | 6.6M | +194.8% | −127M | -1,920.9% | -1.61 | −110M |
| FY2023 | 2.2M | -57.0% | −137M | -6,115.1% | -2.30 | −102M |
| FY2022 | 5.2M | – | −131M | -2,518.4% | -2.96 | −16.6M |
| FY2021 | – | – | −95.8M | –% | -2.96 | −134M |
| FY2020 | – | – | −53.6M | –% | -7.16 | −51.1M |